Vaccines and Related Biological Products Advisory Committee - 10/22/2020 - YouTube
A public meeting of the Vaccines and Related Biological Products Advisory Committee will be held on Oct. 22, 2020, to discuss the general matter of the development, authorization, and/or licensure of vaccines indicated to prevent COVID-19.
Steven Pergam, M.D., M.P.H. Seattle Cancer care Alliance 6:54:19 "My question is, I know that enrollment has been difficult in high-risk groups, particularly the racial minorities. And there's no specification about including the appropriate number in the EUA specifically that I could find that suggest that it would be equal numbers based on what the trials should look like. And I'm concerned that if an EUA's put forward without adequate enrollment in those particular racial minorities that, that might be seen in a negative light. So I'm curious how that was decided and is there any thought about modifying that specifically?"
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.